Author Interviews, JAMA, Pediatrics / 19.05.2016
Erythropoietin Did Not Improve Neurodevelopment in Very Preterm Infants
MedicalResearch.com Interview with:
PD Dr. med. Giancarlo Natalucci
OberarztKlinik für Neonatologie
UniversitätsSpital Zürich
MedicalResearch.com: What is the background for this study?
Dr. Natalucci:: Survival of very preterm infants has increased over the last decades but still they are at risk of developing long-term neurodevelopmental delay. The underlying pathology is termed encephalopathy of prematurity where both structural lesions of the very fragile brain and the disturbance of the physiologic maturational processes are recognized as the main causative entities. Among many pharmacological candidates to prevent brain injury and improve development, erythropoietin has been shown to be among the most promising.
(more…)